A Review on the Current Knowledge on ZIKV Infection and the Interest of Organoids and Nanotechnology on Development of Effective Therapies against Zika Infection

Int J Mol Sci. 2020 Dec 22;22(1):35. doi: 10.3390/ijms22010035.

Abstract

Zika virus (ZIKV) acquired a special relevance due to the pandemic that occurred in the Americas in 2015, when an important number of fetal microcephaly cases occurred. Since then, numerous studies have tried to elucidate the pathogenic mechanisms and the potential therapeutic approaches to combat the virus. Cellular and animal models have proved to be a basic resource for this research, with the more recent addition of organoids as a more realistic and physiological 3D culture for the study of ZIKV. Nanotechnology can also offer a promising therapeutic tool, as the nanoparticles developed by this field can penetrate cells and deliver a wide array of drugs in a very specific and controlled way inside the cells. These two state-of-the-art scientific tools clearly provide a very relevant resource for the study of ZIKV, and will help researchers find an effective treatment or vaccine against the virus.

Keywords: Zika; nanotechnology; organoids; therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Disease Models, Animal
  • Humans
  • Nanomedicine / methods
  • Nanotechnology / methods*
  • Organ Culture Techniques / methods*
  • Organoids / drug effects*
  • Organoids / virology
  • Zika Virus / drug effects*
  • Zika Virus / physiology
  • Zika Virus Infection / drug therapy*
  • Zika Virus Infection / virology

Substances

  • Antiviral Agents